Histologic transformation of lung cancer during pembrolizumab therapy: A case report

著者: Xiaoyan Si, Yan You, Xiaotong Zhang, Hanping Wang, Mengzhao Wang, Li Zhang
出版事項 2020-03-01

Successful treatment of pulmonary inflammatory myofibroblastic tumor with platinum‐pemetrexed: The first report of two cases

著者: Xiaoyan Si, Hanping Wang, Xiaotong Zhang, Mengzhao Wang, Yan You, Li Zhang
出版事項 2020-08-01

Treatment with or without bevacizumab as a first‐line and maintenance therapy for advanced non‐squamous non‐small cell lung cancer: A retrospective study

著者: Jun, Ni, Hanping, Wang, Xiaoyan, Si, Yan, Xu, Mengzhao, Wang, Xiaotong, Zhang, Li, Zhang
出版年 Thorac Cancer (2020)

Recommendations and exploration of diagnosis and treatment of critical and refractory immune checkpoint inhibitor‐associated adverse events

著者: Peng Song, Hanping Wang, Xiaoyan Si, Xiaoxiao Guo, Yue Li, Jiaixin Zhou, Lian Duan, Li Zhang, Mengzhao Wang
出版事項 2020-08-01

Clinical diagnosis and treatment of immune checkpoint inhibitors‐related endocrine dysfunction

著者: Lian Duan, Linjie Wang, Hanping Wang, Xiaoyan Si, Li Zhang, Xiaowei Liu, Yue Li, Xiaoxiao Guo, Jiaxin Zhou, Huijuan Zhu, Li Zhang
出版事項 2020-04-01

Clinical diagnosis and treatment of immune checkpoint inhibitor‐associated pneumonitis

著者: Hanping Wang, Xiaoxiao Guo, Jiaxin Zhou, Yue Li, Lian Duan, Xiaoyan Si, Li Zhang, Xiaowei Liu, Mengzhao Wang, Juhong Shi, Li Zhang
出版事項 2020-01-01

Clinical Diagnosis and Treatment Recommendations for Immune Checkpoint Inhibitor-related Hematological Adverse Events

著者: Junling ZHUANG, Jingting ZHAO, Xiaoxiao GUO, Jiaxin ZHOU, Lian DUAN, Wei QIU, Xiaoyan SI, Li ZHANG, Yue LI, Xiaowei LIU, Hanping WANG, Daobin ZHOU, Li ZHANG
出版事項 2019-10-01